144 related articles for article (PubMed ID: 31087549)
1. Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration.
Coll S; Matabosch X; Llorente-Onaindia J; Carbó ML; Pérez-Mañá C; Monfort N; Monfort J; Ventura R
Drug Test Anal; 2019 Nov; 11(11-12):1589-1600. PubMed ID: 31087549
[TBL] [Abstract][Full Text] [Related]
2. Additional studies on triamcinolone acetonide use and misuse in sports: Elimination profile after intranasal and high-dose intramuscular administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Steroids; 2019 Nov; 151():108464. PubMed ID: 31344406
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Marcos J; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2015 Jan; 145():94-102. PubMed ID: 25260353
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
Knych HK; Vidal MA; Casbeer HC; McKemie DS
Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.
Matabosch X; Pozo OJ; Papaseit E; Farré M; Marcos J; Segura J; Ventura R
Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1829-39. PubMed ID: 25559453
[TBL] [Abstract][Full Text] [Related]
6. Positive doping results caused by the single-dose local injection of triamcinolone acetonide.
Chang CW; Huang TY; Tseng YC; Chang-Chien GP; Lin SF; Hsu MC
Forensic Sci Int; 2014 Nov; 244():1-6. PubMed ID: 25126738
[TBL] [Abstract][Full Text] [Related]
7. Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
Harhay R; Jeelani W; Agbor BTA; Hennon T; Wrotniak BH; Abdul-Aziz R
Pediatr Rheumatol Online J; 2021 Mar; 19(1):36. PubMed ID: 33743721
[TBL] [Abstract][Full Text] [Related]
8. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response.
Gaffney K; Ledingham J; Perry JD
Ann Rheum Dis; 1995 May; 54(5):379-81. PubMed ID: 7794044
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.
Soma LR; Uboh CE; You Y; Guan F; Boston RC
Am J Vet Res; 2011 Sep; 72(9):1234-42. PubMed ID: 21879982
[TBL] [Abstract][Full Text] [Related]
10. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
Kraus VB; Conaghan PG; Aazami HA; Mehra P; Kivitz AJ; Lufkin J; Hauben J; Johnson JR; Bodick N
Osteoarthritis Cartilage; 2018 Jan; 26(1):34-42. PubMed ID: 29024802
[TBL] [Abstract][Full Text] [Related]
11. Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Feb; 13(2):348-359. PubMed ID: 32949107
[TBL] [Abstract][Full Text] [Related]
12. Intra-articular corticoid injection induces circulating glucocorticoid bioactivity and systemic immune activation in juvenile idiopathic arthritis.
Rintamäki H; Tamm K; Vaarala O; Sidoroff M; Honkanen V; Raivio T; Jänne O; Kolho KL
Scand J Rheumatol; 2011; 40(5):347-53. PubMed ID: 21619491
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients.
Weitoft T; Rönnblom L
Ann Rheum Dis; 2006 Jul; 65(7):955-7. PubMed ID: 16769782
[TBL] [Abstract][Full Text] [Related]
14. Dosing of intra-articular triamcinolone hexacetonide for knee synovitis in chronic polyarthritis: a randomized controlled study.
Weitoft T; Öberg K
Scand J Rheumatol; 2019 Jul; 48(4):279-283. PubMed ID: 30843453
[No Abstract] [Full Text] [Related]
15. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients.
Kumar S; Singh RJ; Reed AM; Lteif AN
Pediatrics; 2004 Jun; 113(6):1820-4. PubMed ID: 15173517
[TBL] [Abstract][Full Text] [Related]
16. The effect of intra-articular triamcinolone preparations on blood glucose levels in diabetic patients: a controlled study.
Habib GS; Miari W
J Clin Rheumatol; 2011 Sep; 17(6):302-5. PubMed ID: 21869712
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid and Cortisol Serum Levels Following Intra-articular Triamcinolone Acetonide Lumbar Facet Joint Injections.
Dickson RR; Reid JM; Nicholson WT; Lamer TJ; Hooten WM
Pain Pract; 2018 Sep; 18(7):864-870. PubMed ID: 29436106
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.
Hajialilo M; Ghorbanihaghjo A; Valaee L; Kolahi S; Rashtchizadeh N; Amirkhiz MB; Malekmahdavi I; Khabbazi A
Clin Rheumatol; 2016 Dec; 35(12):2887-2891. PubMed ID: 27572327
[TBL] [Abstract][Full Text] [Related]
19. SporTRIA study-a multicentre trial protocol for excretion kinetics of triamcinolone acetonide following sport-related intra-articular injections in knees: definitions of the washout periods.
Allado E; Poussel M; Gambier N; Saunier V; Starck M; Buisson C; Cinquetti G; Albuisson E; Chenuel B
BMJ Open; 2021 Jun; 11(6):e047548. PubMed ID: 34108168
[TBL] [Abstract][Full Text] [Related]
20. A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration.
Argenti D; Jensen BK; Hensel R; Bordeaux K; Schleimer R; Bickel C; Heald D
J Clin Pharmacol; 2000 Jul; 40(7):770-80. PubMed ID: 10883419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
